By Thomas F. Zuber and Sarah S. Brooks of Zuber & Taillieu
The Federal Circuit recently clarified several aspects of § 1920’s allowances for a prevailing party to charge its costs against the losing party. In In re Ricoh Co., Ltd., 661 F.3d 1361 (Fed. Cir. 2011), the Federal Circuit upheld the use of cost-sharing agreements over default statutory rules, allowed the… More...
Sen. Sam Brownback, R-Kansas, has filed a billed that would prohibit the U.S. Food and Drug Administration (“FDA”) from using federal funds to process biologics license applications for products that contain certain “select agents or toxins.” More...
At a business meeting held on April 2, 2009, the Senate Judiciary Committee voted to report critical legislation to make reforms to the nation’s dated patent reform system. More...
Representatives Anna G. Eshoo (D – CA), Jay Inslee (D – WA), and Joe Barton (R – TX) have introduced the “Pathway for Biosimilars Act” (H.R. 1548). The bill creates a process for approval of “biosimilars” or “follow-on biologics” while protecting patient health and safety, lowering health care costs, and providing adequate incentives for innovation. More...
The Senate Judiciary Committee continued to make progress on patent reform legislation at an executive business meeting Tuesday morning. More...
By a vote of 409-7, the House of Representatives has passed a legislation creating a pilot program to enhance the expertise of district court judges hearing patent cases. More...
House Representatives Henry A. Waxman (CA), Nathan Deal (GA), Frank Pallone, Jr. (NJ), and Jo Ann Emerson (Mo) have introduced H.R. 1427, or a bill “To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes.” More...
Leaders of the Senate and House Judiciary Committees have introduced a bipartisan, bicameral patent reform legislation after the previous session of Congress failed to pass the 2007 version of the bill. More...
After Patrick J. Leahy of Vermont filed in April 2007 a bill entitled "Patent Reform Act of 2007," Senate Minority Whip Jon Kyl of Arizona filed his own bill that he called "Patent Reform Act of 2008. More...
The United States Senate unanimously passed on September 26, 2008 a bill that provides stronger protection to intellectual property (“IP”) rights. Two days later, on motion to suspend the rules, the House of Representatives passed the same legislation by a vote of 381 to 41. The bill will be More...
The Senate has referred to the Committee on Judiciary a bill that will allow for harsher civil penalties to be accessed to those found guilty of violating intellectual property (“IP”) laws and improve the civil remedies available to the victims. The bill, known as the “Enforcement of Intellectual More...
